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Influenza-Associated Pediatric Mortality and the Increase of 
Staphylococcus aureus co-infection
CDC is requesting that states report all cases of influenza-related pediatric mortality from the 
2006-2007 influenza season.
Since 2004, the Influenza-Associated Pediatric Mortality Surveillance System, part of the 
Nationally Notifiable Disease Surveillance System, has collected information on deaths among 
children due to laboratory-confirmed influenza, including the presence of other medical conditions 
and bacterial infections at the time of death. From October 1, 2006 through May 7, 2007, 55 
deaths from influenza in children have been reported to CDC from 23 state health departments 
and two city health departments. Data on bacterial co-infections were reported for 51 cases; 20 
(39%) had a bacterial co-infection, and 16/20 were infected with Staphylococcus aureus. While 
the number of pediatric influenza associated deaths is similar to that reported during the two 
previous years, there has been an increase in the number of deaths in which both influenza 
and pneumonia or bacteremia due to S. aureus were identified. Only one influenza and S. 
aureus co-infection was identified in 2004-2005, and 3 were identified in 2005-2006. O f the 16 
children reported with S. aureus so far in 2006-2007, 11 children had methicillin-resistant 
(MRSA) isolated from a sterile site (9) or sputum (2), and 5 had methicillin-susceptible 
S.aureus isolated from a sterile site (3) or sputum (2). The median age of children with S. aureus 
co-infection was older than children without S.aureus co-infection (11 years versus 4 years, 
p<.01) Children with influenza and S. aureus co-infections were reported to be in good health 
before illness onset but progressed rapidly to severe illness. Influenza strains isolated from these 
children have not been different from common strains circulating in the community and the MRSA 
strains have been typical of those associated with MRSA skin infection outbreaks in the United 
States.
Healthcare providers should be alerted to the possibility of bacterial co-infection among children 
with influenza, and request bacterial cultures when bacterial co-infection is suspected. Clinicians, 
clinical agencies and medical examiners are asked to contact their local or state health 
department as soon as possible when deaths among children due to laboratory-confirmed 
influenza are identified. CDC requests that all cases of pediatric influenza-associated deaths be 
reported promptly by state health departments to CDC through http://sdn.cdc.gov and that 
information about bacterial pathogens isolated from sterile sites and/or from sputum or 
endotracheal aspirates be completed on the Influenza-Associated Pediatric Mortality Surveillance 
System case report form. If the influenza death was complicated by S. aureus infection, please 
contact the clinical agency to determine if the S. aureus isolate is available. CDC is interested in 
receiving S. aureus isolates to better characterize those from fatal cases of influenza in children.
If you have any questions about this Health Advisory, please call the Influenza Division, 
Epidemiology and Prevention Branch at 404-639-3727.
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